Oxybutynin Chloride Tablet shortage

To Be Discontinued

Oxybutynin Chloride Tablet is currently listed as To Be Discontinued in the FDA Drug Shortage Database. Reported reason: Not specified.

Therapeutic category

Renal

Dosage form

Tablet

Routes

ORAL

Last updated

05/14/2025

Strength variants

Not specified

Need sourcing help for Oxybutynin Chloride Tablet?

Get connected with licensed distributors and 503B compounders that can fulfill orders during active shortages. Verified suppliers, no spam.

Connect with a sourcing partner

Manufacturers reporting shortage

Upsher-Smith Laboratories, LLC800-654-2299
To Be Discontinued
Upsher-Smith Laboratories, LLC800-654-2299
To Be Discontinued
Upsher-Smith Laboratories, LLC800-654-2299
To Be Discontinued
Upsher-Smith Laboratories, LLC800-654-2299
To Be Discontinued

Reason for shortage

Not specified

ad slot 300x250

This information is not medical advice. Consult your pharmacist. Data is sourced from the FDA Drug Shortage Database and may not reflect real-time inventory at your facility. ShortageWatch is independent and not affiliated with the FDA.